Shares of Ambu A/S (OTCMKTS:AMBBY – Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $21.80 and last traded at $21.80, with a volume of 400 shares changing hands. The stock had previously closed at $20.05.
Ambu A/S Price Performance
The company has a current ratio of 2.53, a quick ratio of 1.49 and a debt-to-equity ratio of 0.10. The business’s fifty day moving average price is $19.63 and its 200 day moving average price is $17.86. The company has a market capitalization of $5.12 billion and a P/E ratio of 109.00.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last announced its quarterly earnings results on Tuesday, May 14th. The company reported $0.08 EPS for the quarter. The firm had revenue of $199.06 million during the quarter. Ambu A/S had a net margin of 7.23% and a return on equity of 6.80%.
Ambu A/S Company Profile
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Further Reading
- Five stocks we like better than Ambu A/S
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- 3 Best Fintech Stocks for a Portfolio Boost
- MarketBeat Week in Review – 8/12 – 8/16
- 3 Small Caps With Big Return Potential
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
